Similarly, higher rate of lymph node metastasis was observed in patients with tumors highly expressing both IGFIR and VEGF-C (70%) than those of patients with tumors highly expressing only one or none of the molecules (36%). The gene discussed is VEGFC; the disease is metastatic malignant neoplasm in the lymph nodes.